financetom
Business
financetom
/
Business
/
Update: Louisiana-Pacific's Q1 Adjusted Earnings, Net Sales Increase; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Louisiana-Pacific's Q1 Adjusted Earnings, Net Sales Increase; Shares Rise
May 8, 2024 10:12 AM

12:47 PM EDT, 05/08/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.)

Louisiana-Pacific ( LPX ) shares were up 16.5% in recent trading on Wednesday after the company posted Q1 adjusted earnings and net sales ahead of consensus.

The company reported Q1 adjusted earnings of $1.53 per diluted share, up from $0.34 a year earlier.

Analysts polled by Capital IQ expected $1.13.

Net sales for the quarter ended March 31 were $724 million, up from $584 million a year ago.

Analysts surveyed by Capital IQ expected $686.8 million.

Price: 85.00, Change: +12.03, Percent Change: +16.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lazard Insider Sold Shares Worth $4,240,260, According to a Recent SEC Filing
Lazard Insider Sold Shares Worth $4,240,260, According to a Recent SEC Filing
Sep 12, 2025
03:29 AM EDT, 09/12/2025 (MT Newswires) -- Evan L Russo, Chief Executive Officer of Asset Management, on September 09, 2025, sold 75,000 shares in Lazard ( LAZ ) for $4,240,260. Following the Form 4 filing with the SEC, Russo has control over a total of 227,915 common shares of the company, with 227,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1311370/000171748925000003/xslF345X05/wk-form4_1757633247.xml ...
United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing
Sep 12, 2025
03:25 AM EDT, 09/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on September 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,183,777. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled...
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Sep 12, 2025
03:28 AM EDT, 09/12/2025 (MT Newswires) -- Robert W Duggan, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Duggan has control over a total of 591,831,532 common shares of the company, with 556,093,090 shares held directly...
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Sep 12, 2025
03:27 AM EDT, 09/12/2025 (MT Newswires) -- Mahkam Zanganeh, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Zanganeh has control over a total of 591,831,532 common shares of the company, with 31,000 shares held directly and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved